期刊文献+

562例胎儿核型分析及产前诊断指征的探讨 被引量:4

A karyotype analysis on 561 cases of fetuses and discussion on the indications for prenatal diagnosis
原文传递
导出
摘要 目的分析胎儿羊水细胞染色体核型,探讨各种产前诊断指征下染色体异常的检出率。方法对有产前诊断指征的孕中、晚期孕妇进行细胞遗传学产前诊断,比较在各种产前诊断指征下,胎儿染色体异常的检出率。结果羊水细胞培养成功率为95%(562/591),发现异常核型为33例,染色体异常的检出率为5.9%(33/562),三体综合征为15例(45.5%);其中,唐氏综合征为8例,18三体综合征为4例,16三体综合征为1例。在双亲之一携带染色体异常患者中,胎儿异常核型的检出率为50%。超声检查提示,本组胎儿发育异常率为10%(孕妇年龄超过或等于35岁为5.6%),血清学产前筛查高风险为2.6%。结论夫妇一方为染色体异常携带者、超声提示胎儿发育异常、孕妇高龄、血清学产前筛查高风险,是最主要的细胞遗传学产前诊断指征。 Objectives To analyze the chromosomal karyotypes of fetus, and discuss the detection rates of chromosomal abnormalities under different indications for prenatal diagnosis. Methods Cytogenetic prenatal diagnosis were performed on a cohort of pregnant women with different indications in the second- or third-trimester. Detection rates of fetal chromosomal abnormalities under each indication were compared. Results The success rate of amniotic fluid cell culture was 95.1% (562/591), and 33 cases of abnormal karyotypes were found. The detection rate of abnormality was 5. 9% (33/562), including 15 cases of triploid syndromes (45.4%), 8 cases of Down's syndrome, 4 cases of 18-trisomy, and 1 case of 16-trisomy syndrome. The detection rate of abnormal karyotypes was 50~/40 in the pregnant women who or which couple was a carrier of constitutional chromosome abnormality, 10% of the fetuses with abnormal ultrasound founding, 5.6% of pregnant women elder than 35 years old, and 2.6% in high risk pregnancy by serum prenatal screening. Conclusion A carrier of chromosomal abnormality of one of the couple, fetal abnormalities found by ultrasound, elder maternal age, and a high risk result by serum prenatal screening are the most important genetic indications for prenatal diagnosis.
出处 《中华妇幼临床医学杂志(电子版)》 CAS 2007年第6期304-307,共4页 Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition)
基金 云南省自然科学基金重点资助项目(2003C0018Z)
关键词 产前诊断 染色体 核型分析 指征 prenatal diagnosis chromosome karyotype analysis indications
  • 相关文献

参考文献6

  • 1Lee MH;Park SY;Kim YM.Prenatal diagnosis of a familial complex chromosomal rearrangement involving chromosomes[J],2002(02).
  • 2Tseng JJ;Chou MM;Lo FC.Detection of chromosome aberrations in the second trimester using genetic amniocentesis:Experience during 1995-2004,2006(01).
  • 3Mitelman F.ISCN(1995):An international system for human cytogenetic nomenclature,1995.
  • 4王雅荪,罗军,王慧,徐慧君,沈歈忱,孟文珍,沈颖华,潘顺.孕中期11297例母血筛查胎儿唐氏综合征临床分析[J].中国优生与遗传杂志,2007,15(1):32-33. 被引量:27
  • 5杜维霞,赫飞,傅颖华,楚严,徐丽梅,陈德清.908例胎儿羊水细胞染色体核型分析[J].中国优生与遗传杂志,2006,14(5):41-42. 被引量:8
  • 6Kong CW;Leung TN;Leung TY.Risk factors for procedure-related fetal losses after mid-trimester genetic amniocentesis[J],2006(10).

二级参考文献12

  • 1刘权章.人类染色体方法学[M].北京:人民卫生出版社,1992.136.
  • 2Felder S,Werblow A,Robra BP.A priori and optimal test accuracy in prenatal diagnostics[J].Med Decis Making,2003,23(5):406-413.
  • 3Dimitrova V,Markov D,Chernev T,et al.Ultrasound screening for Down syndrome and other chromosomal abnormalities by fetal nuchal translucency measurement between 11-14 weeks of gestation[J].Akush Ginekol(Sofiia),2005,44(1):32-37.
  • 4Merkatz IR, Nitowsky HM, Macri JN, et al. An association between low maternal serum alpha - fetopretein and fetal chromosomal abnormalities[J]. Am J Ohetet Gynecol,1984,148(7) :886 -894.
  • 5Bogart MH,Pandian MR,Jones OW. Abnormal maternal serum chorlonie gonadotrepin levels in pregnancies with fetal chromosome abnormalities[J]. Prenat Diagn,1987,7(9) :623 -630.
  • 6Haddw JE, Palomaki GE, Knight GT, et al. Prenatal screening for Down's Syndrome with use of maternal serum markers[ J]. N Engl J Meal,1992,327(9) :588 -593.
  • 7Wald NS, Kennard A, Hackshaw A, et al. Antenatal screening for Down's Syndrome[ J ]. J Med Screen, 1997,4 (4) : 181 - 246.
  • 8Wold NS, Cockle HS, Densem JM, et al. Matemal serum screening for Down' s Syndrome in early pregnanecy [ J ]. BMJ, 1988, 297 (6653) :883 - 887.
  • 9Maeri JN,Anderson RW,Krantz DA,et al, Prenatal Maternal dried blood screening with alpha - fetoprotein and free Beta - human chorionic gonedotropin for open neural tube defect an Down Syndrome[ J]. Am J Obetet Gvnecol, 1996.174 ( 2 ) :556 - 572.
  • 10陆国辉 陈天健 黄尚志 等.产前诊断及其在国内应用的分析.中国优生与遗传杂志,2003,11(1):1-5.

共引文献33

同被引文献25

  • 1朱宝生,焦存仙,朱姝,董旭东,胡云英,刘云霞,冯怀英,刘娟,唐新华,张云霞,王瑞红,祝杏珍,章晓梅.唐氏综合征发生率及其受产前筛查干预的研究[J].中华妇幼临床医学杂志(电子版),2005,1(1):20-22. 被引量:31
  • 2王斌,陈英耀,石琦,张洁,李军,钱序,朱怡蓓.我国唐氏综合征的疾病经济负担研究[J].中国卫生经济,2006,25(3):24-26. 被引量:90
  • 3段涛,边旭明,向阳,孙路明.我国产前诊断的现状与展望[J].现代妇产科进展,2006,15(2):81-91. 被引量:55
  • 4张月萍,徐建忠,殷民,陈美芳,任德麟.染色体平衡易位携带者妊娠风险及妊娠结局的研究[J].中华妇产科杂志,2006,41(9):592-596. 被引量:37
  • 5左仅,等.医学遗传学[M].复旦大学出版社,1998:173.
  • 6Taliemural M, Suzumofilk, Nishikawa N, et al. Multicolour spectral karyotyping for complex chromosomal rearrangements in repeated abortion or congenital anomalies [ J ]. Prenat Diagn,2001,21 : 1123 - 1128.
  • 7Cuckle HS,Wald NJ,Lindenbaum RH.Maternal serum alphafetoprotein measurement:a screening test for Down syndrome.Lancet,1984,1:926-929.
  • 8Wald NJ,Rodeck C,Hackshaw AK,et al.First and second trimester antenatal screening for Down's syndrome:the results of the Serum,Urine and Ultrasound Screening Study (SURUSS).Health Technol Assess,2003,7:1-77.
  • 9Berry BJ,Li Z,Erickson JD,et al.Prevention of neural-tube defects with folic acid in China.China-U.S.Collaborative Project for Neural Tube Defect Prevention. N Engl J Med,1999,341:1485-1490.
  • 10De Wals P,Tairou F,Van Allen MI,et al.Reduction in neuraltube defects after folic acid fortification in Canada.N Engl J Med,2007,357:135-142.

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部